Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.

Patents 2show all

  • 1
    C07C - Acyclic or carbocyclic compounds
  • 1
    C07D - Heterocyclic compounds
  • 1
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 1
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Contact Information

86 rue de Paris, Bâtiment Mélèze
Orsay 91400
France

Overview

Total FundingEmployeesLast Funding DateStatus
$11,914,87511-502006-02-28Closed

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2003-01-01Series A
2006-02-28$11,914,875Series BTruffle Capital, Andera PartnersSociete Generale Asset Management